Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirokuni Taguchi

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
International Journal of Molecular Medicine|July 10, 2003
Identification of a new GLC1A mutation in a sporadic, primary open-angle glaucoma in JapanTakayuki Ikezoe, Seisho Takeuchit, Naoki Komatsu, et al.
Cancer Science|August 2, 2005
HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signalingYang Yang, Takayuki Ikezoe, Tamotsu Takeuchi, et al.
Cancer Science|August 19, 2006
Effect of SU11248 on gastrointestinal stromal tumor-T1 cells: enhancement of growth inhibition via inhibition of 3-kinase/Akt/mammalian target of rapamycin signalingTakayuki Ikezoe, Yang Yang, Chie Nishioka, et al.
Leukemia Research|February 7, 2006
HIV-1 protease inhibitor ritonavir potentiates the effect of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of human myeloid leukemia cells via down-regulation of CYP24Takayuki Ikezoe, Kentaro Bandobashi, Yang Yang, et al.
Cancer Research|June 3, 2005
CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cellsTakayuki Ikezoe, Sigal Gery, Dong Yin, et al.
Oncology Reports|June 10, 2005
Methylation of the MLH1 gene in hematological malignanciesMasahide Matsushita, Seisho Takeuchi, Yang Yang, et al.
Molecular Cancer Therapeutics|October 17, 2006
The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signalingTakayuki Ikezoe, Chie Nishioka, Taizo Tasaka, et al.
Japanese Journal of Cancer Research : Gann|June 25, 2002
Establishment and characterization of a new lung cancer cell line (MI-4) producing high levels of granulocyte colony stimulating factorRyoji Harada, Yoshiki Uemura, Makoto Kobayashi, et al.
Cancer Research|October 20, 2004
HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivoTakayuki Ikezoe, Yasuko Hisatake, Tamotsu Takeuchi, et al.
British Journal of Haematology|December 11, 2002
Genetic polymorphisms in the tumour necrosis factor locus in childhood acute lymphoblastic leukaemiaSeisho Takeuchi, Naoko Takeuchi, Kunihiro Tsukasaki, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Molecular Medicine|July 10, 2003
Identification of a new GLC1A mutation in a sporadic, primary open-angle glaucoma in JapanTakayuki Ikezoe, Seisho Takeuchit, Naoki Komatsu, et al.
Cancer Science|August 2, 2005
HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signalingYang Yang, Takayuki Ikezoe, Tamotsu Takeuchi, et al.
Cancer Science|August 19, 2006
Effect of SU11248 on gastrointestinal stromal tumor-T1 cells: enhancement of growth inhibition via inhibition of 3-kinase/Akt/mammalian target of rapamycin signalingTakayuki Ikezoe, Yang Yang, Chie Nishioka, et al.
Leukemia Research|February 7, 2006
HIV-1 protease inhibitor ritonavir potentiates the effect of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of human myeloid leukemia cells via down-regulation of CYP24Takayuki Ikezoe, Kentaro Bandobashi, Yang Yang, et al.
Cancer Research|June 3, 2005
CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cellsTakayuki Ikezoe, Sigal Gery, Dong Yin, et al.
Oncology Reports|June 10, 2005
Methylation of the MLH1 gene in hematological malignanciesMasahide Matsushita, Seisho Takeuchi, Yang Yang, et al.
Molecular Cancer Therapeutics|October 17, 2006
The antitumor effects of sunitinib (formerly SU11248) against a variety of human hematologic malignancies: enhancement of growth inhibition via inhibition of mammalian target of rapamycin signalingTakayuki Ikezoe, Chie Nishioka, Taizo Tasaka, et al.
Japanese Journal of Cancer Research : Gann|June 25, 2002
Establishment and characterization of a new lung cancer cell line (MI-4) producing high levels of granulocyte colony stimulating factorRyoji Harada, Yoshiki Uemura, Makoto Kobayashi, et al.
Cancer Research|October 20, 2004
HIV-1 protease inhibitor, ritonavir: a potent inhibitor of CYP3A4, enhanced the anticancer effects of docetaxel in androgen-independent prostate cancer cells in vitro and in vivoTakayuki Ikezoe, Yasuko Hisatake, Tamotsu Takeuchi, et al.
British Journal of Haematology|December 11, 2002
Genetic polymorphisms in the tumour necrosis factor locus in childhood acute lymphoblastic leukaemiaSeisho Takeuchi, Naoko Takeuchi, Kunihiro Tsukasaki, et al.
Pageof 8